Clinical Trial Update: C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for C7R-GD2.CAR T cells targeting GD2-expressing brain tumors, currently recruiting for DIPG, high-grade glioma, embryonal tumor, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Embryonal Tumor
• Ependymal Tumor
• High-grade Glioma

Drugs mentioned

• C7R-GD2.CAR T Cells

Snippet

Sponsor: Baylor College of Medicine | Conditions: Diffuse Intrinsic Pontine Glioma, High Grade Glioma | Phase 1 | Status: RECRUITING